Suppr超能文献

评价大黄牡丹汤中大黄素、木犀草素和丹皮酚组合改善溃疡性结肠炎的疗效和安全性。

Evaluating the efficacy and safety of emodin, luteolin, and paeonol combination from Dahuang Mudan decoction in ameliorating ulcerative colitis.

作者信息

Chen Ke-Han, Xu Rui, Ye Hua-Jian, Xu Bo, Cao Shui-Ling, Chen Hong-Xu, Chen Yun-Liang, Cai Yan-Ping, Xie Xue-Qian, Zhao Meng, Zhou Lian, Luo Xia

机构信息

School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.

School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.

出版信息

J Ethnopharmacol. 2025 Apr 25;346:119692. doi: 10.1016/j.jep.2025.119692. Epub 2025 Mar 27.

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

Dahuang Mudan Decoction is a classic Chinese medicine prescription for treating ulcerative colitis (UC). Previous studies have shown that Dahuang Mudan Decoction has preventive and therapeutic effects on mice with dextran sulfate sodium (DSS) induced colitis.

AIM OF THE STUDY

The objective of this research endeavor was to ascertain the most efficacious synergistic blend of Emodin, Luteolin, and Paeonol, the main active ingredients in Dahuang Mudan Decoction, in alleviating UC. Additionally, it sought to elucidate the underlying therapeutic mechanisms and evaluate the safety of the combined components.

MATERIALS AND METHODS

Employing Emodin, Luteolin, and Paeonol as starting materials, the optimal combination was selected by orthogonal design. Basic pharmacodynamics was observed in mouse model of UC induced by DSS. The pathological changes of the colon were observed using hematoxylin and eosin (H&E) staining. The changes of cytokines and proteins related to inflammation and intestinal barrier function were detected by WB, Alcian blue staining, immunofluorescence, immunohistochemistry and related kits. Subsequently, 16S rRNA sequencing was used to observe changes in the intestinal flora. To evaluate the therapeutic effect and potential mechanism of the optimal monomer composition on UC mouse model. Finally, we performed toxicity tests as part of the safety assessment of the combination of the three monomers.

RESULTS

The different combinations of Emodin, Luteolin, and Paeonol alleviated DSS-induced colitis to varying degrees. The ELP5 group (Emodin 5 mg/kg + Luteolin 5 mg/kg + Paeonol 15 mg/kg) and ELP9 group (Emodin 15 mg/kg + Luteolin 15 mg/kg + Paeonol 75 mg/kg) had the most significant mitigation effect on UC mice. Mechanistically, the monomeric composition provides a comprehensive treatment for UC by addressing multiple aspects, including anti-inflammatory and antioxidant effects, repairing the damaged intestinal barrier, restoring the intestinal flora structure, and regulating short-chain fatty acid levels. In addition, the combination of Emodin, Luteolin and Paeonol exhibited a more significant effect on DSS-induced colitis compared to the individual components, indicating a synergistic effect among them. In the single-dose toxicity test, no obvious abnormalities were found in the general state or major organs of the mice. In repeated toxicity tests, it was found that the combined use of three monomers had less effect on organ index, hematology and serum biochemical indexes than that of a single compound. Pathological examination showed that the three monomers had certain toxicity to mouse liver, kidney and lung when used alone and in large doses for a long time, and the toxicity was significantly reduced after combined use.

CONCLUSIONS

We have determined the optimal combination of three active ingredients in Dahuang Mudan Decoction to alleviate DSS induced colitis in mice by inhibiting intestinal inflammation and oxidative stress, repairing impaired intestinal barrier function, and regulating intestinal flora disturbance. The results of single administration toxicity test proved the safety of the three monomers combined, and repeated administration toxicity test clarified the safe dose range of the combined administration, and also revealed that the combined therapy exhibited superior safety compared to monotherapy.

摘要

民族药理学相关性

大黄牡丹汤是治疗溃疡性结肠炎(UC)的经典中药方剂。以往研究表明,大黄牡丹汤对葡聚糖硫酸钠(DSS)诱导的结肠炎小鼠具有预防和治疗作用。

研究目的

本研究旨在确定大黄牡丹汤主要活性成分大黄素、木犀草素和丹皮酚缓解UC的最有效协同组合。此外,还试图阐明其潜在的治疗机制并评估组合成分的安全性。

材料与方法

以大黄素、木犀草素和丹皮酚为原料,通过正交设计选择最佳组合。在DSS诱导的UC小鼠模型中观察基本药效学。用苏木精-伊红(H&E)染色观察结肠的病理变化。通过蛋白质免疫印迹法(WB)、阿尔辛蓝染色、免疫荧光、免疫组织化学及相关试剂盒检测与炎症和肠道屏障功能相关的细胞因子和蛋白质的变化。随后,采用16S rRNA测序观察肠道菌群的变化。以评估最佳单体组合对UC小鼠模型的治疗效果和潜在机制。最后,作为三种单体组合安全性评估的一部分,我们进行了毒性试验。

结果

大黄素、木犀草素和丹皮酚的不同组合对DSS诱导的结肠炎有不同程度的缓解作用。ELP5组(大黄素5mg/kg + 木犀草素5mg/kg + 丹皮酚15mg/kg)和ELP9组(大黄素15mg/kg + 木犀草素15mg/kg + 丹皮酚75mg/kg)对UC小鼠的缓解作用最为显著。机制上,该单体组合通过抗炎、抗氧化、修复受损肠道屏障、恢复肠道菌群结构和调节短链脂肪酸水平等多方面对UC进行综合治疗。此外,大黄素、木犀草素和丹皮酚的组合对DSS诱导的结肠炎的作用比单一成分更显著,表明它们之间存在协同作用。在单次给药毒性试验中,小鼠的一般状态或主要器官未发现明显异常。在重复给药毒性试验中,发现三种单体联合使用对器官指数、血液学和血清生化指标的影响比单一化合物小。病理检查表明,三种单体单独长期大剂量使用时对小鼠肝脏、肾脏和肺有一定毒性,联合使用后毒性显著降低。

结论

我们确定了大黄牡丹汤中三种活性成分的最佳组合,通过抑制肠道炎症和氧化应激、修复受损的肠道屏障功能以及调节肠道菌群紊乱来缓解DSS诱导的小鼠结肠炎。单次给药毒性试验结果证明了三种单体联合的安全性,重复给药毒性试验明确了联合给药的安全剂量范围,并且还表明联合治疗比单一治疗具有更高的安全性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验